These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36338164)

  • 41. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Search for familial hypercholesterolemia patients in an Italian community: A real-life retrospective study.
    Fasano T; Trenti C; Negri EA; Guiducci V; Foracchia M; Bonelli E; Canovi S; Besutti G; Bertolini S; Calandra S
    Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):577-585. PubMed ID: 35123858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
    Paquette M; Cariou B; Bernard S; Hegele RA; Gallo A; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):505-512. PubMed ID: 38031840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients.
    Masana L; Zamora A; Plana N; Comas-Cufí M; Garcia-Gil M; Martí-Lluch R; Ponjoan A; Alves-Cabratosa L; Elosua R; Marrugat J; Dégano IR; Ramos R
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31340450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India.
    Puri R; Mehta V; Duell PB; Nair D; Mohan JC; Yusuf J; Dalal JJ; Mishra S; Kasliwal RR; Agarwal R; Mukhopadhyay S; Wardhan H; Khanna NN; Pradhan A; Mehrotra R; Kumar A; Puri S; Muruganathan A; Sattur GB; Yadav M; Singh HP; Agarwal RK; Nanda R
    J Clin Lipidol; 2020; 14(2):e1-e13. PubMed ID: 32089456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.
    Vallejo-Vaz AJ; Packard CJ; Ference BA; Santos RD; Kastelein JJP; Stein EA; Catapano AL; Pedersen TR; Watts GF; Ray KK
    Atherosclerosis; 2021 Mar; 320():1-9. PubMed ID: 33497862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Severe hypercholesterolaemia--when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts' group statement].
    Cybulska B; Gaciong Z; Hoffman P; Jankowski P; Kłosiewicz-Latoszek L; Kaźmierczak J; Mitręga K; Opolski G; Pająk A; Ponikowski P; Rynkiewicz A; Stępińska J; Średniawa B; Kalarus Z
    Kardiol Pol; 2016; 74(4):394-8. PubMed ID: 27098076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study.
    Meshkov AN; Ershova AI; Kiseleva AV; Shalnova SA; Drapkina OM; Boytsov SA; On Behalf Of The Fh-Esse-Rf Investigators
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34074024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial hypercholesterolemia and atherosclerotic cardiovascular mortality among Korean adults with low levels of serum cholesterol.
    Jung KJ; Koh H; Choi Y; Lee SJ; Ji E; Jee SH
    Atherosclerosis; 2018 Nov; 278():103-109. PubMed ID: 30261470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).
    Tarugi P; Bertolini S; Calandra S; Arca M; Angelico F; Casula M; Cefalù AB; D'Erasmo L; Fortunato G; Perrone-Filardi P; Rubba P; Suppressa P; Averna M; Catapano AL
    Nutr Metab Cardiovasc Dis; 2024 May; ():. PubMed ID: 38871496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
    Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
    Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
    Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
    J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
    Tada H; Kawashiri MA; Nomura A; Teramoto R; Hosomichi K; Nohara A; Inazu A; Mabuchi H; Tajima A; Yamagishi M
    J Clin Lipidol; 2018; 12(6):1436-1444. PubMed ID: 30241732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.